Antibody-based drug discovery at the speed of light

Article

Sponsored Content

The combination of the PentaMice® platform and single B cell screening with the Beacon® system increases speed to market for monoclonal antibody antibody therapeutics.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content
© 2025 MJH Life Sciences

All rights reserved.